Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors

Extracellular glutamate accumulation following cerebral ischemia leads to overactivation of glutamate receptors, thereby resulting in intracellular Ca2+ overload and excitotoxic neuronal injury. Multiple attempts have been made to counteract such effects by reducing glutamate receptor function, but...

Full description

Bibliographic Details
Main Authors: Yongjun Sun, Xue Feng, Yue Ding, Mengting Li, Jun Yao, Long Wang, Zibin Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2019.00168/full
id doaj-7bff4441996245ffb0219a7c0d3f21c1
record_format Article
spelling doaj-7bff4441996245ffb0219a7c0d3f21c12020-11-24T20:46:35ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022019-04-011310.3389/fncel.2019.00168447810Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate ReceptorsYongjun Sun0Yongjun Sun1Xue Feng2Yue Ding3Mengting Li4Jun Yao5Long Wang6Zibin Gao7Zibin Gao8Department of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, ChinaHebei Research Center of Pharmaceutical and Chemical Engineering, Hebei University of Science and Technology, Shijiazhuang, ChinaHebei University of Science and Technology, Shijiazhuang, ChinaShijiazhuang Vocational College of Technology and Information, Shijiazhuang, ChinaDepartment of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, ChinaDepartment of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, ChinaDepartment of Family and Consumer Sciences, California State University, Long Beach, CA, United StatesDepartment of Pharmacy, Hebei University of Science and Technology, Shijiazhuang, ChinaState Key Laboratory Breeding Base—Hebei Province Key Laboratory of Molecular Chemistry for Drug, Shijiazhuang, ChinaExtracellular glutamate accumulation following cerebral ischemia leads to overactivation of glutamate receptors, thereby resulting in intracellular Ca2+ overload and excitotoxic neuronal injury. Multiple attempts have been made to counteract such effects by reducing glutamate receptor function, but none have been successful. In this minireview, we present the available evidence regarding the role of all types of ionotropic and metabotropic glutamate receptors in cerebral ischemia and propose phased treatment strategies based on glutamate receptors in both the acute and post-acute phases of cerebral ischemia, which may help realize the clinical application of glutamate receptor antagonists.https://www.frontiersin.org/article/10.3389/fncel.2019.00168/fullcerebral ischemiaexcitotoxicityphased treatment strategiesglutamate receptorsglutamate receptor antagonist
collection DOAJ
language English
format Article
sources DOAJ
author Yongjun Sun
Yongjun Sun
Xue Feng
Yue Ding
Mengting Li
Jun Yao
Long Wang
Zibin Gao
Zibin Gao
spellingShingle Yongjun Sun
Yongjun Sun
Xue Feng
Yue Ding
Mengting Li
Jun Yao
Long Wang
Zibin Gao
Zibin Gao
Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
Frontiers in Cellular Neuroscience
cerebral ischemia
excitotoxicity
phased treatment strategies
glutamate receptors
glutamate receptor antagonist
author_facet Yongjun Sun
Yongjun Sun
Xue Feng
Yue Ding
Mengting Li
Jun Yao
Long Wang
Zibin Gao
Zibin Gao
author_sort Yongjun Sun
title Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
title_short Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
title_full Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
title_fullStr Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
title_full_unstemmed Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors
title_sort phased treatment strategies for cerebral ischemia based on glutamate receptors
publisher Frontiers Media S.A.
series Frontiers in Cellular Neuroscience
issn 1662-5102
publishDate 2019-04-01
description Extracellular glutamate accumulation following cerebral ischemia leads to overactivation of glutamate receptors, thereby resulting in intracellular Ca2+ overload and excitotoxic neuronal injury. Multiple attempts have been made to counteract such effects by reducing glutamate receptor function, but none have been successful. In this minireview, we present the available evidence regarding the role of all types of ionotropic and metabotropic glutamate receptors in cerebral ischemia and propose phased treatment strategies based on glutamate receptors in both the acute and post-acute phases of cerebral ischemia, which may help realize the clinical application of glutamate receptor antagonists.
topic cerebral ischemia
excitotoxicity
phased treatment strategies
glutamate receptors
glutamate receptor antagonist
url https://www.frontiersin.org/article/10.3389/fncel.2019.00168/full
work_keys_str_mv AT yongjunsun phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT yongjunsun phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT xuefeng phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT yueding phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT mengtingli phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT junyao phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT longwang phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT zibingao phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
AT zibingao phasedtreatmentstrategiesforcerebralischemiabasedonglutamatereceptors
_version_ 1716812289576796160